Earlier this month, Beta Bionics presented clinical trial data to the American Diabetes Association (ADA) on its insulin-only bionic pancreas — called the iLet Bionic Pancreas — for use in...
Sanofi recently launched its first-in-pharma Diversity, Equity, & Inclusion (DE&I) Board to encourage an inclusive and diverse culture that enables breakthrough innovations.
The...
FDA recently issued draft guidance to enroll more participants from underrepresented racial and ethnic populations in the United States into trials, expanding overall clinical trial...
Bristol Myers Squibb recently granted $7.965 million to 24 US non-profit organizations to improve access to care for medically underserved patients across oncology, cardiology, immunology, and...
Health equity is crucial to ensuring access for all individuals to essential care. And pharmaceutical and biotechnology companies are pushing for necessary long-term changes to better meet the needs of...
